ALK-positive Large B-Cell Lymphoma Presenting as a Circumscribed Breast Mass with Germinal Center Immunophenotype

被引:2
作者
Yan, Mingfei [1 ]
Khattab, Ruba [1 ]
Meyerson, Howard [1 ]
机构
[1] Univ Hosp Cleveland, Med Ctr, Dept Pathol, Cleveland, OH 44106 USA
关键词
ALK positive; large B cell lymphoma; breast; germinal center phenotype; CD10; BCL6; IDENTIFICATION; CRIZOTINIB; EXPRESSION; FUSION; STAT3;
D O I
10.1177/10668969221099627
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We report a rare case of ALK-positive large B cell lymphoma which initially presented as a circumscribed breast mass in a young woman mimicking fibroadenoma. The lymphoma demonstrated typical immunoblastic morphology with monomorphic round nuclei and prominent central nucleoli. Immunophenotypically, the lymphoma was positive for MUM1,CD138, BOB1, OCT2, PAX5 (focal), CD4, and was negative for CD20, CD79a and all other T cell antigens. Immunostaining for the ALK protein revealed the characteristic granular cytoplasmic staining typical for ALK-positive large B cell lymphoma with an ALK::CTCL fusion confirmed on genomic profiling study. Notably the cells also expressed CD10 and BCL6. Staging revealed disseminated disease with blood, bone marrow and liver involvement. To our knowledge, this is the first report of ALK-positive large B cell lymphoma initially presenting as a breast lesion. Additionally, expression of CD10 and BCL6 suggested a germinal center origin for the lesion.
引用
收藏
页码:233 / 238
页数:6
相关论文
共 15 条
  • [1] Castillo JJ., 2021, LEUKEMIA LYMPHOMA, V62, P1
  • [2] Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance
    Cattoretti, Giorgio
    Shaknovich, Rita
    Smith, Paula M.
    Jack, Hans-Martin
    Murty, Vundavalli V.
    Alobeid, Bachir
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 177 (10) : 6930 - 6939
  • [3] Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target
    Chiarle, R
    Simmons, WJ
    Cai, HY
    Dhall, G
    Zamo', A
    Raz, R
    Karras, JG
    Levy, DE
    Inghirami, G
    [J]. NATURE MEDICINE, 2005, 11 (06) : 623 - 629
  • [4] STAT3-mediated up-regulation of BLIMP1 is coordinated with BCL6 down-regulation to control human plasma cell differentiation
    Diehl, Sean A.
    Schmidlin, Heike
    Nagasawa, Maho
    van Haren, Simon D.
    Kwakkenbos, Mark J.
    Yasuda, Etsuko
    Beaumont, Tim
    Scheeren, Ferenc A.
    Spits, Hergen
    [J]. JOURNAL OF IMMUNOLOGY, 2008, 180 (07) : 4805 - 4815
  • [5] Identification of a novel GORASP2-ALK fusion in an ALK-positive large B-cell lymphoma
    Ise, Mikiko
    Kageyama, Hajime
    Araki, Akinobu
    Itami, Makiko
    [J]. LEUKEMIA & LYMPHOMA, 2019, 60 (02) : 493 - 497
  • [6] Identification of RANBP2-ALK fusion in ALK positive diffuse large B-cell lymphoma
    Lee, Seung Eun
    Kang, So Young
    Takeuchi, Kengo
    Ko, Young Hyeh
    [J]. HEMATOLOGICAL ONCOLOGY, 2014, 32 (04) : 221 - 224
  • [7] Li J, 2015, INT J CLIN EXP MED, V8, P6977
  • [8] ALK-positive large B-cell lymphoma with strong CD30 expression; a diagnostic pitfall and resistance to brentuximab and crizotinib
    Mehra, Varun
    Pomplum, Sabine
    Ireland, Robin
    Yallop, Deborah
    Devereux, Stephen
    Marcus, Robert
    Shah, Chirag
    Patten, Piers
    Kassam, Shireen
    [J]. HISTOPATHOLOGY, 2016, 69 (05) : 880 - 882
  • [9] ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript:: report of 2 cases
    Onciu, M
    Behm, FG
    Downing, JR
    Shurtleff, SA
    Raimondi, SC
    Ma, Z
    Morris, SW
    Kennedy, W
    Jones, SC
    Sandlund, JT
    [J]. BLOOD, 2003, 102 (07) : 2642 - 2644
  • [10] ALK-positive Large B-cell Lymphoma A Clinicopathologic Study of 26 Cases With Review of Additional 108 Cases in the Literature
    Pan, Zenggang
    Hu, Shimin
    Li, Min
    Zhou, Yi
    Kim, Young S.
    Reddy, Vishnu
    Sanmann, Jennifer N.
    Smith, Lynette M.
    Chen, Mingyi
    Gao, Zifen
    Wang, Huan-You
    Yuan, Ji
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (01) : 25 - 38